Multiple sclerosis and immune regulatory cells

By Antel Jack   Owens Trevor  

Brain, Vol. 127, Iss. 9, 2004-09 ,pp. : 1915-1916

Oxford University Press

Access to resources Recommend Favorite

Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis

By Stasiolek Mariusz   Bayas Antonios   Wieczarkowiecz Anja   Toyka Klaus V.   Gold Ralf  

Brain, Vol. 129, Iss. 5, 2006-05 ,pp. : 1293-1305

Oxford University Press

Access to resources Recommend Favorite

Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair

By Markovic-Plese Silva   Singh Avtar K   Singh Inderjit  

Future Neurology, Vol. 3, Iss. 2, 2008-03 ,pp. : 153-167

Future Medicine

Access to resources Recommend Favorite

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity

By Wiendl Heinz   Feger Ute   Mittelbronn Michel   Jack Carolyn   Schreiner Bettina   Stadelmann Christine   Antel Jack   Brueck Wolfgang   Meyermann Richard   Bar-Or Amit   Kieseier Bernd C.   Weller Michael  

Brain, Vol. 128, Iss. 11, 2005-11 ,pp. : 2689-2704

Oxford University Press

Access to resources Recommend Favorite

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment

By Krumbholz Markus   Theil Diethilde   Cepok Sabine   Hemmer Bernhard   Kivisäkk Pia   Ransohoff Richard M.   Hofbauer Monika   Farina Cinthia   Derfuss Tobias   Hartle Caroline   Newcombe Jia   Hohlfeld Reinhard   Meinl Edgar  

Brain, Vol. 129, Iss. 1, 2006-01 ,pp. : 200-211

Oxford University Press

Access to resources Recommend Favorite